Qms Medical Allied Services Limited · NSE:QMSMEDI
Qms Medical Allied Services — Investor Presentation (September 2023)
25 slides from Qms Medical Allied Services's investor presentation, Sep 8, 2023
Slide 1: NSE Regulation 30 Announcement Cover Letter
To, National Stock Exchange of India Ltd. Plaza, C 1, Block G, Bandra - Kurla Complex, Bandra (E), Mumbai – 400 051, Maharashtra, India. Company Symbol: QMSMEDI ISIN: INE0FMW01018 Ref: QMS MEDICAL ALLIED SERVICES LIMITED Sub: Announcement under Regulation 30 of Securities and Exchange Board of India
Slide 2: QMS Medical Allied Services Limited Investor Presentation
QMS MEDICAL ALLIED SERVICES LIMITED Investor Presentation
Slide 3: Company Overview
COMPANY OVERVIEW
Slide 4: About The Company
3 About The Company QMS Medical Allied Services Limited (QMS, The Company) is engaged in the marketing and distribution of a wide range of medical and healthcare devices and accessories. 3 600 + 130 + Business Verticals SKUs Customers The Company market and distribute these products to various end u
Slide 5: Business Verticals
4 Business Verticals Medical Devices And Continuing Medical Patient Services Program Equipment Education Service (CME) QMS Medical Allied Services Limited
Slide 6: Medical Devices And Equipment
5 Medical Devices And Equipment Medical Devices Glucose Monitoring Kit and Blood Pressure Monitor Diagnostic machines ECG Fetal Doppler Glucose Monitoring Strips Test Kits Thermometer Nebulizer Opthalmoscope Otoscope Oxygen Concentrator Pulse Oximeter Skin Stapler Stethoscope QMS Medical Allied Serv
Slide 7: Medical Devices And Equipment
6 Medical Devices And Equipment Medical Consumables { Disinfection Filters Infection prevention tools Personal protection like PPE kits Miscellaneous products Compression bandages Wound management dressing kits Dental products QMS Medical Allied Services Limited
Slide 8: Q Devices
7 Q Devices QMS Medical Allied Services Limited
Slide 9: Q Devices
8 Q Devices Blood Pressure Nano Ionic Monitor Steamer Nebulizer Portable Body Massager QMS Medical Allied Services Limited
Slide 10: Continuing Medical Education Service (CME)
9 Continuing Medical Education Service (CME) Authorised by EACME QMS also offers a range of evidence-based, scientific content medical programs, which are (European Academy of CME) used in updating clinical knowledge and practices. Continuing medical education (CME) is a valuable mechanism to update
Slide 11: Patient Services Program
10 Patient Services Program CAMPS Offerings The also organize various preventive and diagnostic camps in various therapy areas at our o Diabetic Retinopathy Health Care Partner o Continuous ECG o HbA1c (HCP) clinics pan o ABPM o Continuous Glucose India on behalf of o Lipid Profile monitoring variou
Slide 12: Patient Services Program Device Portfolio
11 Patient Services Program Device Portfolio Smart Cardia Contec ABPM50 Carl Zeiss Visuscout Keeler Tonocare Biosense A1 Chek Vibrasense (Holter ECG) (ABPM Machine) 100 (Fundus cope) (Tonometry) (HBA1c mcahine) (Biothesiometer) Lysun blood lipid Sonost 3000 Freestyle Libre Statsensor Xpresss HB Chek
Slide 13: Key Management
Key Management MR. MAHESH MAKHIJA Promoter, Chairperson & Managing Director Age: 53 years He has around 28 years of rich experience in the field of medical and healthcare devices. He is currently responsible for formulating business strategies and oversight of day to day functioning of the Company.
Slide 14: Industry Overview
INDUSTRY OVERVIEW
Slide 15: Medical Device Industry Overview
14 Medical Device Industry Overview India is the 4th largest Asian Medical Devices Market in The Indian market for medical As of May 2021, the medical devices medical devices market after Japan, India (In US$ Bn) equipment is predicted to increase market is estimated to be at US$ 12 China, and South
Slide 16: Financial Overview
FINANCIAL OVERVIEW
Slide 17: Profit & Loss Statement
16 Profit & Loss Statement In ₹ Cr Particulars FY21 FY22 FY23 Revenues 122.03 146.32 104.04 Other Income 0.06 1.42 0.74 Total Revenue 122.09 147.74 104.78 Raw Material costs 90.41 110.43 77.88 Employee costs 2.38 4.67 3.72 Other expenses 12.35 14.90 11.11 Total Expenditure 105.14 130.00 90.72 EBITDA
Slide 18: Q1 FY24 vs Q1 FY23 Results
17 In ₹ Cr Particulars Q1 FY24 Q1 FY23 Y-O-Y % FY23 FY22 Y-O-Y% Net Sales 25.96 24.51 104.04 146.32 Other Income 0.08 0.17 0.74 1.42 Total Income 26.04 24.68 104.78 147.75 Expenses Raw Material costs 16.34 18.75 77.88 110.44 Employee Benefit Expenses 1.02 0.70 3.72 4.67 Other Expenses 3.94 3.38 11.1
Slide 19: Balance Sheet
18 Balance Sheet In ₹ Cr Equities & Liabilities FY21 FY22 FY23 Assets FY21 FY22 FY23 Equity 3.76 3.76 17.85 Non Current Assets Reserves 16.56 27.27 52.55 Fixed assets 10.18 7.97 26.52 Net Worth 20.32 31.03 70.40 Non-current investments 0.00 0.00 0.00 Non-current Liabilities Deferred Tax Assets 0.00
Slide 20: Key Financial Highlights
19 Key Financial Highlights Total Revenue In ₹ Cr EBITDA In ₹ Cr EBITDA EBITDA Margin 147.74 122.09 13.88 20.00 104.78 12.01 11.51 15.00 10.00 5.00 16.95 17.74 12.07 0.00 FY21 FY22 FY23 FY21 FY22 FY23 NET PROFIT In ₹ Cr Earnings Per Share Considering Bonus In ₹ Net Profit Net Profit Margin 14.00 9.6
Slide 21: Key Ratios
20 Key Ratios Return On Equity In % Return On Capital Employed In % 53.69 40.60 26.32 34.51 21.33 9.06 FY21 FY22 FY23 FY21 FY22 FY23 Debt To Equity In Times Book Value Considering Bonus In ₹ 39.44 1.03 1.03 27.49 18.01 0.96 FY21 FY22 FY23 FY21 FY22 FY23 QMS Medical Allied Services Limited
Slide 22: Revenue From Top 10 Customers
21 Revenue From Top 10 Customers FY21 Sales FY22 Sales FY23 Sales 7.13 11 13.83 122.09 Cr 146.32 Cr 104.04 Cr 86.17 89 92.87 Top 10 Others QMS Medical Allied Services Limited
Slide 23: Stock Information and Share Holding Pattern
22 Stock Information Share Holding Pattern As on 08-09-2023 As on 31-03-2023 NSE Code QMSMEDI Bloomberg QMSMEDI-IN ISIN INE0FMW01018 25.12% Promoters Share Price ₹ 143.90 Market Capitalization ₹ Cr 256.86 Institution No. of Share Outstanding 1,78,50,000 1.21% NII Face Value ₹ 10 73.67% 52 Week High
Slide 24: Disclaimer
23 Disclaimer This presentation or any other documentation or information (or any part thereof) delivered or supplied should not be deemed to constitute prospectus or placement memorandum or an offer to acquire any securities. N o representation or warranty, express or implied is made as to, and no r
Slide 25: Thank You
Kirin Advisors Private Limited Contact: Vastupal Shah Phone: +91 22 4100 2455 Website: www.kirinadvisors.com E-mail: vastupal@kirinadvisors.com THANK YOU Content, Concept & Design by QMS Medical Allied Services Limited 1A-B/2A-B, Navkala Bharti Building, Plot No.16, Prabhat Colony, Road No.3, Santac
QMS Medical Allied Services — Investor Presentation (September 2023) on 6ix